Average cost of drugs for extensively drug-resistant tuberculosis in Ukraine
Ukraine: Average cost of drugs for extensively drug-resistant tuberculosis was 1,566 constant 2022 US$ in 2024. ▼ Falling
Average cost of drugs for extensively drug-resistant tuberculosis in Ukraine, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
The most recent figure for average cost of drugs for extensively drug-resistant tuberculosis in Ukraine is 1,566 constant 2022 US$, measured in 2024. That is the lowest value across all 8 years on record.
Compared with earlier readings it is down 52.3% on the previous year and down 71.3% over ten years.
Ukraine ranks 31st of 56 countries on this measure, in the middle of the range.
Average cost of drugs for extensively drug-resistant tuberculosis in Ukraine, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 5,455 constant 2022 US$ | — |
| 2018 | 5,442 constant 2022 US$ | -0.2% |
| 2019 | 5,296 constant 2022 US$ | -2.7% |
| 2020 | 4,130 constant 2022 US$ | -22.0% |
| 2021 | 5,535 constant 2022 US$ | +34.0% |
| 2022 | 3,918 constant 2022 US$ | -29.2% |
| 2023 | 3,283 constant 2022 US$ | -16.2% |
| 2024 | 1,566 constant 2022 US$ | -52.3% |
Ukraine compared with similar countries
- Ukraine's 1,566 constant 2022 US$ is below the median for upper middle income countries, which is 2,000 constant 2022 US$, 78% of the median. (23 countries reporting)
- Ukraine's 1,566 constant 2022 US$ is below the median for Europe & Central Asia, which is 4,345 constant 2022 US$, 36% of the median. (8 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 5,398 constant 2022 US$ | 5,296 constant 2022 US$ | 5,455 constant 2022 US$ | 3 |
| 2020s | 3,686 constant 2022 US$ | 1,566 constant 2022 US$ | 5,535 constant 2022 US$ | 5 |
Countries ranked near Ukraine
More reference data data for Ukraine
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 2.72 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 0.8321 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 8.98 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 1.92 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 8.98 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 9.11 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 5.76 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 3.97 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 43.91 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 10.47 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Ukraine?
- Average cost of drugs for extensively drug-resistant tuberculosis in Ukraine was 1,566 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Ukraine?
- The highest recorded value was 5,535 constant 2022 US$ in 2021.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Ukraine?
- The lowest recorded value was 1,566 constant 2022 US$ in 2024.
- How does Ukraine rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Ukraine ranks 31st out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Ukraine?
- Over the last ten years it is down 71.3%. The long-run trend across the full record is falling.
- Where does this Ukraine data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.